ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: To further challenge the scalability of μPhos, we also applied it to study time-resolved drug responses in murine pro-B lymphocyte Ba/F3 BCR::ABL1 positive cells, a pre-clinical model of chronic myeloid leukemia (CML).